Shopping Cart
Remove All
Your shopping cart is currently empty
PAR4 antagonist4 (Compound 37) is a selective antagonist of protease-activated receptor 4 (PAR4). It exhibits antiplatelet activity with an IC50 of 14.2 nM. Moreover, PAR4 antagonist3 enhances metabolic stability in human liver microsomes, showing a half-life (T1/2) of 42.5 minutes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PAR4 antagonist4 (Compound 37) is a selective antagonist of protease-activated receptor 4 (PAR4). It exhibits antiplatelet activity with an IC50 of 14.2 nM. Moreover, PAR4 antagonist3 enhances metabolic stability in human liver microsomes, showing a half-life (T1/2) of 42.5 minutes. |
| Targets&IC50 | PAR4:14.2 nM |
| In vitro | PAR4 antagonist 4 (4 μM) acts against GPVI, inhibiting the collagen-induced platelet aggregation signaling pathway. |
| In vivo | PAR4 antagonist 4, administered orally at doses of 3-12 mg/kg as a single dose, prolongs bleeding time in the tail-cut model of C57BL/J6 mice without affecting the coagulation system. |
| Molecular Weight | 453.44 |
| Formula | C22H16FN3O5S |
| Cas No. | 3057206-41-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.